Mansi Shah, MD, explains how treatment sequencing and patient eligibility guide the use of these therapies in multiple ...

Stem cell mobilization and transplantation represent pivotal advances in the management of multiple myeloma. ... and the optimisation of supportive care during the transplant process [2].

CAR T-cell therapy may cure up to 40% of patients with lymphoma and is an option for those who can’t receive transplants, ...

Like many closely-knit mothers and daughters, Noreen and Anne Hennessy love nothing more than hitting the shops together at ...

While presenting the data at this year's American Society of Clinical Oncology (ASCO) annual meeting, Peter Voorhees, MD, of ...

At 38, author Jonathan Gluck was diagnosed with blood cancer and given less than three years to live. Twenty-two years later, ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The news comes the same week that the LVHN's Topper Cancer institute cut the ribbon on a 30-bed stem cell transplant center. "This is momentous for the Lehigh Valley in that up till now patients ...

Non-dilutive NIH funding supports development of MiNK's allogeneic iNKT platform for immune regulation in high-risk HSCT settings. NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc.